According to the Centers for Disease Control and Prevention (CDC), the 2017-2018 flu season was one of the most severe — excluding pandemics — on record.
The 2017-2018 influenza season in the United States (October 1, 2017-May 19, 2018) was a high-severity season.
The New Drug Application for baloxavir marboxil is supported by results from the Phase 3 CAPSTONE-1 study, which examined the effects of a single dose of baloxavir marboxil vs placebo or oseltamivir 75mg twice daily for 5 days.
Results still indicate a trajectory toward stricter infection prevention at hospitals in general, and highlight a possible need for increased vaccine mandates.
The advisory comes early as physicians are currently placing vaccine orders.
Optimal distribution of the influenza vaccine across age groups can increase the impact of even low-efficacy vaccines.
This updated Committee Opinion includes more recent data on the safety and efficacy of influenza vaccination during pregnancy, as well as recommendations for treatment and postexposure chemoprophylaxis.
Although substantial emphasis is placed on vaccinations in considering how to limit the spread of influenza, simple hygienic methods have been found to be the most effective and should be more widely supported.
Lawyers make things complicated — including policies requiring mandatory influenza vaccinations for healthcare workers.
The CDC continues to recommend flu vaccination at this time.
Improvement in Influenza Vaccination Rates With Combination Patient Portal Messaging, Interactive Phone CallsFebruary 14, 2018
Patient portal and voice call notifications resulted in a "small but significant" improvement in vaccination rates.
Unlike broad-spectrum UVC light, far-UVC light has not been linked to skin cancer or cataracts.
The H3N2 strain of influenza has been predominant in the 2017-2018 influenza season.
Researchers observed a significant association between respiratory infections and acute myocardial infarction.
The AAP Committee on Infectious Diseases released recommendations regarding influenza, influenza immunization, and influenza treatment for the 2017-2018 season.
Researchers from NIH's National Institute of Allergy and Infectious Diseases aimed to develop a universal influenza vaccine that would confer better and longer-lasting protection against the influenza virus.
Results show that annual vaccination lessens flu severity, hospitalizations, and death among the elderly.
Current vaccines are likely to be effective against H3N2 flu viruses in the 2017/2018 flu season.
Influenza activity in the United States was low during October 2017, but started increasing in November.
The Minnesota-based hospital chain fired nearly 50 employees for refusal to receive the influenza vaccine.
One additional high-risk patient was immunized for every 29 messages sent.
Hospital-based healthcare personnel had the highest frequency of working with influenza-like illness.
More than 78% of health care personnel and 54% of pregnant women received influenza vaccine during the 2016-17 influenza season.
Microneedle patches used for the influenza vaccine are tolerated just as well as using a needle and syringe.
The inactivated influenza vaccine was 60% effective among children, while the live attenuated vaccine was found to be ineffective.
High-dose influenza vaccination can reduce risk of respiratory-related hospitalization among nursing home residents.
There is a sure-fire way for us to gain an upper hand with the flu virus, though. It's simple: get more people vaccinated.
There was wide variation by state in vaccination coverage among tier 1 and health care personnel groups.
Influenza vaccine effectiveness was 51% among children with high-risk conditions and 65% overall.
The more severe H3N2 strain is a factor in reduced coverage.